4.4 Review

Blood Sugar Targets in Surgical Intensive Care Management and Special Considerations in Patients With Diabetes

期刊

DEUTSCHES ARZTEBLATT INTERNATIONAL
卷 118, 期 38, 页码 629-+

出版社

DEUTSCHER AERZTE-VERLAG GMBH
DOI: 10.3238/arztebl.m2021.0221

关键词

-

向作者/读者索取更多资源

In the perioperative period, 30-80% of patients in intensive care develop hyperglycemia, with diabetic patients not benefiting as much from blood sugar reduction as metabolically healthy individuals. Therefore, blood sugar control in perioperative patients should focus on avoiding hypoglycemia while keeping blood glucose concentration under 10 mmol/L.
Background: 30-80% of patients being treated in intensive care units in the perioperative period develop hyperglycemia. This stress hyperglycemia is induced and maintained by inflammatory-endocrine and iatrogenic stimuli and generally requires treatment. There is uncertainty regarding the optimal blood glucose targets for patients with diabetes mellitus. Methods: This review is based on pertinent publications retrieved by a selective search in PubMed and Google Scholar. Results: Patients in intensive care with pre-existing diabetes do not benefit from blood sugar reduction to the same extent as metabolically healthy individuals, but they, too, are exposed to a clinically relevant risk of hypoglycemia. A therapeutic range from 4.4 to 6.1 mmol/L (79-110 mg/dL) cannot be justified for patients with diabetes mellitus. The primary therapeutic strategy in the perioperative setting should be to strictly avoid hypoglycemia. Neurotoxic effects and the promotion of wound-healing disturbances are among the adverse consequences of hyperglycemia. Meta-analyses have shown that an upper blood sugar limit of 10 mmol/L (180 mg/dL) is associated with better outcomes for diabetic patients than an upper limit of less than this value. The target range of 7.8-10 mmol/L (140-180 mg/dL) proposed by specialty societies for hospitalized patients with diabetes seems to be the best compromise at present for optimizing clinical outcomes while avoiding hypoglycemia. The method of choice for achieving this goal in intensive care medicine is the continuous intravenous administration of insulin, requirng standardized, high-quality monitoring conditions. Conclusion: Optimal blood sugar control for diabetic patients in intensive care meets the dual objectives of avoiding hypoglycemia while keeping the blood glucose concentration under 10 mmol/L (180 mg/dL). Nutrition therapy in accordance with the relevant guidelines is an indispensable pre requisite.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据